Overview

Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study proposes to examine the effect of TMG therapy upon the cellular elements within the central (bone marrow) and peripheral (lymph node) lymphoid compartments of humans. Briefly, bone marrow aspirates and lymph nodes will be obtained at the time of transplant, from renal transplant recipients receiving TMG induction therapy. For comparative purposes, peripheral blood samples will also be obtained. Lymphocytes from these compartments will be assessed for CD antigen expression, apoptosis, cytokine production following memory immune responses, and functional assays to assess potential regulatory T-cell (Treg) activity.
Phase:
N/A
Details
Lead Sponsor:
Swedish Medical Center
Collaborator:
Genzyme, a Sanofi Company
Treatments:
Antilymphocyte Serum
Thymoglobulin